Request A Demo

Author: admin

Seno Medical and “Know Your Lemons” Team Up For Breast Cancer Education

Partnership emphasizes breast health education and empowers women SAN ANTONIO, May 12, 2019 – Seno Medical Instruments, Inc. (Seno Medical), a Texas-based medical imaging company developing breakthrough breast cancer diagnostic technology, announced an educational partnership supporting Worldwide Breast Cancer’s “Know Your Lemons” campaign starting with the Netherlands, which has one of the highest breast cancer […]

Multiple Publications and Presentations Underscore Seno Medical’s Value Proposition in Mitigating the Cost and Burden of Unnecessary Breast Biopsies

SAN ANTONIO, January 8, 2019 – Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic ultrasound (OA/US) imaging to differentiate benign from malignant masses, today provided a summary of key 2018 data publications and presentations that demonstrate the clinical utility and healthcare economic benefits of its proprietary, […]

New Data Demonstrate That Seno Medical’s Opto-Acoustic Imaging Technology Offers A Non-Invasive Approach to Differentiating Breast Cancer Molecular Subtypes

–  Company’s technology, which shows promise as a clinical prognostic tool that may facilitate treatment decisions, featured as a High Impact Clinical Trial at the Radiological Society of North America Annual Meeting for second year in a row – SAN ANTONIO, Dec. 11, 2018 /PRNewswire/ — Seno Medical Instruments, Inc. (Seno Medical), the leader in new […]

Seno Medical: Making a Difference for Breast Cancer in San Antonio

–  San Antonio-based technology company focuses on improving breast cancer diagnostic accuracy and ‘walking the talk’ inside the company – SAN ANTONIO, November 12, 2018 – Local diagnostic imaging system developer, Seno Medical, is taking a serious stance against breast cancer. Not only does this innovator work toward a better imaging device beyond mammography and ultrasound with […]

Annual Cost of False-Positive Breast Biopsies Exceeds $2 Billion According to Recent Study

–  Publication in ClinicoEconomics and Outcomes Research estimates nearly $8 billion annually in expense for additional breast diagnostic testing, underscoring market need for improved breast diagnostic tools – SAN ANTONIO, May 31, 2018 – False-positive breast biopsies in the United States cost the healthcare system more than $2 billion per year, according to findings released from a new study in ClinicoEconomics […]

New Analytics Approach Offers Potential of Reducing Unnecessary Breast Biopsies

–  Publication in AJR defines advanced statistical methods that can be used with diagnostic imaging output to downgrade breast mass risk classification – SAN ANTONIO, May 3, 2018 – The American Journal of Roentgenology recently published findings on statistical methods for downgrading the risk classification of breast masses to reduce the need for unnecessary breast biopsies. Clinicians from Seno […]